NexgenRX Inc. (NXG) — Capital Reinvestment Ratio
Latest as of September 2025:
0.02x
NexgenRX Inc. (NXG) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$880.82K) in capital expenditures (CA$18.07K). See NXG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
CA$880.82K
CAD
Capital Expenditures
CA$18.07K
CAD
Data as of
Sep 2025
Most recent filing
NexgenRX Inc. Capital Reinvestment Ratio (2013–2024)
This chart tracks NexgenRX Inc.'s Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for NexgenRX Inc. (2013–2024)
Year-by-year Capital Reinvestment Ratio for NexgenRX Inc. from 2013 to 2024. For live market cap and broader valuation context, see NexgenRX Inc. (NXG) total market value.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CA$1.15 Million | CA$317.69K | ▲ +42.0% |
| 2023 | 0.19x | CA$1.28 Million | CA$248.41K | ▼ -46.7% |
| 2022 | 0.36x | CA$1.07 Million | CA$388.81K | ▲ +1002.2% |
| 2021 | 0.03x | CA$3.82 Million | CA$126.55K | ▼ -27.3% |
| 2020 | 0.05x | CA$2.65 Million | CA$120.74K | ▼ -6.3% |
| 2019 | 0.05x | CA$1.05 Million | CA$50.78K | ▼ -93.3% |
| 2016 | 0.72x | CA$490.96K | CA$355.00K | ▲ +1084.7% |
| 2013 | 0.06x | CA$774.08K | CA$47.24K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow